Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis (Q63229293)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis |
clinical trial |
Statements
A Randomized, Double-blinded, Placebo Controlled Study to Evaluate Clinical Efficacy and Safety of Pirfenidone for Skin Fibrosis in Systemic Sclerosis (English)
0 references
May 2017
0 references
April 2019
0 references
72
0 references
18 year
0 references
70 year
0 references